Literature DB >> 20590407

Synthesis, spectral characterization, and in vitro antibacterial and antifungal activities of novel 1,3-thiazine-2-amines comprising morpholine nucleus.

J Thanusu1, V Kanagarajan, M Gopalakrishnan.   

Abstract

A collection of 4-(4-morpholinophenyl)-6-aryl-6H-1,3-thiazin-2-amines (20-28) were synthesized and their in vitro antimicrobial activity was investigated. Compound 21 against P. aeruginosa, 23 against B. subtilis, 24 against V. cholerae and P. aeruginosa, 26 against S. aureus and B. subtilis, 27 against B. subtilis and E. coli, and 28 against all tested bacterial strains exerted excellent antibacterial activity. Compound 20 against A. flavus and Rhizopus, 21, 26 against Rhizopus, 22, 27 against Mucor, 23 against A. flavus, 24 against both A. flavus and Mucor, 25 against all tested strains, and 28 against Rhizopus and M. gypseum exerted excellent antifungal activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590407     DOI: 10.3109/14756360903389898

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  3 in total

1.  Biochemical composition, antimicrobial and antifungal activities assessment of the fermented medicinal plants extract using lactic acid bacteria.

Authors:  Hamza Gadhoumi; E L Akrem Hayouni; Enriqueta Martinez-Rojas; Walid Yeddes; Moufida Saidani Tounsi
Journal:  Arch Microbiol       Date:  2022-06-08       Impact factor: 2.552

2.  In vitro microbiological evaluation of 1,1'-(5,5'-(1,4-phenylene)bis(3-aryl-1H-pyrazole-5,1-(4H,5H)-diyl))diethanones, novel bisacetylated pyrazoles.

Authors:  Vijayakumar Kanagarajan; Muthuvel Ramanathan Ezhilarasi; Mannathusamy Gopalakrishnan
Journal:  Org Med Chem Lett       Date:  2011-09-20

3.  Evaluation of the effect of 2-(2,4-dihydroxyphenyl)-4H-benzofuro[3,2-d][1,3]thiazin-4-one on colon cells and its anticancer potential.

Authors:  Arkadiusz Czerwonka; Marta K Lemieszek; Monika Karpińska; Joanna Matysiak; Andrzej Niewiadomy; Wojciech Rzeski
Journal:  Med Chem Res       Date:  2018-07-25       Impact factor: 1.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.